Cosentus Holdings, an Irvine-based provider of revenue cycle management (RCM) and integrated business solutions for ...
Brensocatib effectively reduces NSP activity in bronchiectasis patients, with greater reductions observed in the 25-mg dose group compared to the 10-mg group.